Brief: Clearpoint Neuro Inc Plans To Commence Limited Market Release In First Half Of 2024
16/01/2024 13:02
Jan 16 (Reuters) - Clearpoint Neuro Inc CLPT.O :
* CLEARPOINT NEURO ANNOUNCES FDA CLEARANCE FOR SMARTFRAME
OR™
STEREOTACTIC SYSTEM
* CLEARPOINT NEURO INC - PLANS TO COMMENCE LIMITED MARKET
RELEASE
IN FIRST HALF OF 2024
* CLEARPOINT NEURO INC - PLANNED FULL MARKET RELEASE IN
SECOND
HALF OF 2024
Source text for Eikon: ID:nGNX769Y3R
Further company coverage: CLPT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clearpoint Neuro
See all newsClearpoint Neuro Inc reports results for the quarter ended June 30 - Earnings Summary
ClearPoint Neuro Q2 revenue rises 18% but misses estimates
Brief: ClearPoint Neuro Q2 Revenue USD 10.9 Million
ClearPoint Neuro Q1 revenue rises 43%, beats estimates
ClearPoint Neuro Q4 revenue rises on IRRAS acquisition